S. H. Lee

发表

Cancer cell estrogen receptor of human mammary carcinoma

S. H. Lee, Sin Hang Lee, Sin Hang Lee, 1979, Cancer.

Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience

H. Sze, D. Lam, D. Poon, 2016, BMC Urology.

Discrepancies of the Values on the Withholding Futile Interventions between Physician and Family Members of Terminal Cancer Patients.

Y. Bang, D. Heo, D. Y. Kim, 2001, Cancer research and treatment : official journal of Korean Cancer Association.

Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10–17)

J. Ahn, Y. Choi, D. You, 2014, British Journal of Cancer.

Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor.

D. Kim, D. Lee, Y. Jeon, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma.

D. Heo, S. Khwarg, S. H. Lee, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung Cancer.

Y. Bang, J. Kim, D. Heo, 2001, Cancer research and treatment : official journal of Korean Cancer Association.

Efficacy of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer.

D. H. Lee, Y. Bang, J. Kim, 2001, Cancer research and treatment : official journal of Korean Cancer Association.

A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer.

Y. Bang, Y. Kim, J. Kim, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

J. Ahn, J. Kim, Y. Im, 2008, Cancer Chemotherapy and Pharmacology.

HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients.

M. Ahn, W. Park, V. Anagnostou, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes.

H. G. Kim, S. Kim, Jiwon Kim, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.